Avantor, Inc. (AVTR)

Market Cap	7.74B
Revenue (ttm)	6.67B
Net Income (ttm)	687.40M
Shares Out	681.43M
EPS (ttm)	1.01
PE Ratio	11.25
Forward PE	11.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,918,918
Open	11.94
Previous Close	13.44
Day's Range	10.83 - 12.24
52-Week Range	10.83 - 27.83
Beta	0.96
Analysts	Buy
Price Target	19.45 (+71.22%)
Earnings Date	Aug 1, 2025

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 17, 2019
• Employees: 13,500
• Stock Exchange: NYSE
• Ticker Symbol: AVTR
• Website: https://www.avantorsciences.com

Financial Performance

In 2024, Avantor's revenue was $6.78 billion, a decrease of -2.64% compared to the previous year's $6.97 billion. Earnings were $711.50 million, an increase of 121.58%.

Analyst Summary

According to 11 analysts, the average rating for AVTR stock is "Buy." The 12-month stock price target is $19.45, which is an increase of 71.22% from the latest price.

Price Target

$19.45

(71.22% upside)

Analyst Consensus: Buy